Correlation Between Citigroup and Curative Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citigroup and Curative Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Curative Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Curative Biosciences, you can compare the effects of market volatilities on Citigroup and Curative Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Curative Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Curative Biosciences.

Diversification Opportunities for Citigroup and Curative Biosciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Citigroup and Curative is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Curative Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Curative Biosciences and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Curative Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Curative Biosciences has no effect on the direction of Citigroup i.e., Citigroup and Curative Biosciences go up and down completely randomly.

Pair Corralation between Citigroup and Curative Biosciences

Taking into account the 90-day investment horizon Citigroup is expected to generate 0.25 times more return on investment than Curative Biosciences. However, Citigroup is 3.94 times less risky than Curative Biosciences. It trades about 0.11 of its potential returns per unit of risk. Curative Biosciences is currently generating about -0.09 per unit of risk. If you would invest  4,567  in Citigroup on August 29, 2024 and sell it today you would earn a total of  2,408  from holding Citigroup or generate 52.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Citigroup  vs.  Curative Biosciences

 Performance 
       Timeline  
Citigroup 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain fundamental indicators, Citigroup exhibited solid returns over the last few months and may actually be approaching a breakup point.
Curative Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Curative Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Curative Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Citigroup and Curative Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citigroup and Curative Biosciences

The main advantage of trading using opposite Citigroup and Curative Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Curative Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Curative Biosciences will offset losses from the drop in Curative Biosciences' long position.
The idea behind Citigroup and Curative Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation